Results
|
5601.
|
|
|
5602.
|
Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. [electronic resource] by
- Boonstra, Jurjen J
- van Marion, Ronald
- Beer, David G
- Lin, Lin
- Chaves, Paula
- Ribeiro, Catarina
- Pereira, A Dias
- Roque, Lúcia
- Darnton, S Jane
- Altorki, Nasser K
- Schrump, David S
- Klimstra, David S
- Tang, Laura H
- Eshleman, James R
- Alvarez, Hector
- Shimada, Yutaka
- van Dekken, Herman
- Tilanus, Hugo W
- Dinjens, Winand N M
Producer: 20100316
In:
Journal of the National Cancer Institute vol. 102
Availability: No items available.
|
|
5603.
|
|
|
5604.
|
Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant. [electronic resource] by
- Lierman, Els
- Folens, Cedric
- Stover, Elizabeth H
- Mentens, Nicole
- Van Miegroet, Helen
- Scheers, Werner
- Boogaerts, Marc
- Vandenberghe, Peter
- Marynen, Peter
- Cools, Jan
Producer: 20060912
In:
Blood vol. 108
Availability: No items available.
|
|
5605.
|
|
|
5606.
|
|
|
5607.
|
|
|
5608.
|
|
|
5609.
|
|
|
5610.
|
|
|
5611.
|
Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. [electronic resource] by
- Pinter, Matthias
- Hucke, Florian
- Graziadei, Ivo
- Vogel, Wolfgang
- Maieron, Andreas
- Königsberg, Robert
- Stauber, Rudolf
- Grünberger, Birgit
- Müller, Christian
- Kölblinger, Claus
- Peck-Radosavljevic, Markus
- Sieghart, Wolfgang
Producer: 20120719
In:
Radiology vol. 263
Availability: No items available.
|
|
5612.
|
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. [electronic resource] by
- Lachenmayer, Anja
- Toffanin, Sara
- Cabellos, Laia
- Alsinet, Clara
- Hoshida, Yujin
- Villanueva, Augusto
- Minguez, Beatriz
- Tsai, Hung-Wen
- Ward, Stephen C
- Thung, Swan
- Friedman, Scott L
- Llovet, Josep M
Producer: 20120917
In:
Journal of hepatology vol. 56
Availability: No items available.
|
|
5613.
|
|
|
5614.
|
|
|
5615.
|
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. [electronic resource] by
- Shi, Ying-Hong
- Ding, Zhen-Bin
- Zhou, Jian
- Hui, Bo
- Shi, Guo-Ming
- Ke, Ai-Wu
- Wang, Xiao-Ying
- Dai, Zhi
- Peng, Yuan-Fei
- Gu, Cheng-Yu
- Qiu, Shuang-Jian
- Fan, Jia
Producer: 20120330
In:
Autophagy vol. 7
Availability: No items available.
|
|
5616.
|
|
|
5617.
|
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors. [electronic resource] by
- Morgillo, F
- Cascone, T
- D'Aiuto, E
- Martinelli, E
- Troiani, T
- Saintigny, P
- De Palma, R
- Heymach, J V
- Berrino, L
- Tuccillo, C
- Ciardiello, F
Producer: 20110916
In:
British journal of cancer vol. 105
Availability: No items available.
|
|
5618.
|
|
|
5619.
|
|
|
5620.
|
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib. [electronic resource] by
- Sharma, Manish
- Ravandi, Farhad
- Bayraktar, Ulas Darda
- Chiattone, Alexandre
- Bashir, Qaiser
- Giralt, Sergio
- Chen, Julianne
- Qazilbash, Muzaffar
- Kebriaei, Partow
- Konopleva, Marina
- Andreeff, Michael
- Cortes, Jorge
- McCue, Deborah
- Kantarjian, Hagop
- Champlin, Richard E
- de Lima, Marcos
Producer: 20120531
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 17
Availability: No items available.
|